Media

Filter by Category

All Blog News Newsletters Podcasts Presentations Press Releases Publications Videos

Filter by Program

Filter by Publish Date

Digital Health Technologies Hold Key to New Parkinson’s Treatments

Global stakeholders come together to collaborate with urgency to address unmet needs for Parkinson’s therapies. TUCSON, Ariz., J

Launch of UNITE4TB Partnership Marks a New Era in Tuberculosis Treatment Development

The partnership will accelerate the development of new Tuberculosis (TB) drug regimens as part of the Innovative Medicines Initiat

C-Path Announces Health Care Leader Appointment to Board of Directors

TUCSON, Ariz., July 8, 2021 — Critical Path Institute (C-Path) today announced the appointment of health care industry leader

July 8, 2021

Digital Progression Biomarkers as Novel Endpoints in Clinical Trials: A Multistakeholder Perspective

Stephenson D, Badawy R, Mathur S, Tome M, Rochester L. Digital Progression Biomarkers as Novel Endpoints in Clinical Trials...

REQUEST FOR PROPOSAL: OMOP CDM Mapping, Training, and Consulting

C-Path’s Data Collaboration Center’s Data Science Team is seeking proposals from U.S.-based vendors to provide expertise a

June 27, 2021-July 1, 2021

The Rare Disease Clinical Outcome Assessment Consortium: Collaboration Aimed at Accelerating Rare Disease Drug Development

Presented at the DIA Virtual Global Annual Meeting, held June 27 – July 1, 2021.

Clinical Technology Expert and Experienced Neuroscientist Join C-Path in Executive Director Roles

Scottie Kern and Dr. Terina N. Martínez Will Both Serve in Dual Positions TUCSON, Ariz., June 24, 2021 — Critical Path Instit

July 21, 2021

View Now | How RDCA-DAP Can Help Inform Optimal Trial Design in Progressive Rare Disease

When: July 21, 2021, 12 p.m. ET Case Study: Northstar Ambulatory Assessment as an outcome assessment in Duchenne muscular

July 15, 2021-July 26, 2021

VIEW NOW | Design of Clinical Trials in New-Onset Type 1 Diabetes: Regulatory Considerations for Drug Development

Critical Path Institute held a free virtual workshop, Design of Clinical Trials in New-Onset Type 1 Diabetes: Regulatory Cons

July 16, 2021

View Now | RDCA-DAP Webinar Series: Value of Integrated Data and Analytics in Rare Disease Drug Development

When: June 16, 2021, 12 p.m. ET Case Study: Modeling disease progression in polycystic kidney disease to inform tr

Previous5758 59...130 Next